HexemBio Raises $10.4M Seed for Stem Cell Rejuvenation
SOSV portfolio company HexemBio recently spoke with Axios following its new $10.4 million Seed funding led by Draper Associates, with participation from SOSV, Seraphim, and others. The company is...